There is a clear correlation between increased serum levels of FGF21 and metabolic disease conditions such as diabetes, mitochondrial diseases, obesity, and aging, all of which have muscle loss as a common factor (for review, see Tezze et al. 2019). This evidence concerns the gene FGF21 and metabolic disease.